Medicine Description newclav 642.9 mg / 5 ml
newclav 642.9 mg / 5 ml oral suspension is a medication that combines amoxicillin, a broad-spectrum penicillin antibiotic, with clavulanic acid, a beta-lactamase inhibitor. Amoxicillin functions by binding to specific penicillin-binding proteins (PBPs) located on the bacterial cell wall, leading to disruption of cell wall synthesis and ultimately resulting in bacterial cell lysis and death. However, some bacteria produce beta-lactamase enzymes that can inactivate amoxicillin. Clavulanic acid inhibits these enzymes, thereby protecting amoxicillin from degradation and extending its antibacterial efficacy against resistant strains. This synergistic action allows Newclav to effectively combat a wider range of bacterial infections.
Indications and Uses of newclav 642.9 mg / 5 ml oral suspension
- Treatment of pneumonia
- Management of sinusitis
- Treatment of bacterial skin infections
- Management of acute otitis media
- Elimination of Staphylococcus aureus infections
- Treatment of urinary tract infections
- Treatment of dental infections
- Management of intra-abdominal infections
Side Effects of newclav 642.9 mg / 5 ml oral suspension
- Diarrhea
- Nausea
- Vomiting
- Rash
- Allergic reactions
- Abdominal pain
- Headache
Storage and Handling
Store Newclav oral suspension in a cool, dry place away from direct sunlight. Once reconstituted, keep it refrigerated and use within the specified timeframe indicated on the packaging.
Patient Advice and Precautions
Ensure to complete the entire course of therapy as prescribed, even if symptoms improve. Be aware of potential allergic reactions, especially if there is a history of penicillin allergy. If any severe side effects such as difficulty breathing or severe rash occur, seek medical attention immediately. Inform your healthcare provider about all medications you are taking to avoid potential interactions.